As CEO of the Morgridge Institute for Research, I am reminded every time I enter our building of the extraordinary vision, commitment and generosity of John and Tashia Morgridge. The entire University of Wisconsin community received another wonderful reminder last week, with the announcement $100 million lead gift that represents a brilliant investment in the heart of a great university.
Drs. Brad Schwartz, CEO of the Morgridge Institute for Research; Terri Young, Chair of the Department of Ophthalmology and Visual Sciences (DOVS); and David Gamm, Director of the McPherson Eye Research Institute (MERI); are pleased to announce the recipient of the $25,000 grant award for Metabolism Research in Age-Related Macular Degeneration. This pilot award is funded by the Morgridge Institute and the James Christenson Estate Macular Degeneration Research Fund.
Bill Swisher, the assistant vice president for corporate and institutional partnerships at Carnegie Mellon University (CMU), has been named the new chief development officer of the Morgridge Institute for Research.
Infectious diseases have large-scale human impact, and virology research works to tackle current issues while building knowledge to prepare for future threats and to provide more broad spectrum controls. John and Jeanne Rowe have provided long-term support for Ahlquist’s research group, which studies viruses like HIV, human papillomavirus and Chikungunya.
Asked why he became a biochemist, Jim Dahlberg reflected briefly and answered, “I always found science exciting, interesting, and relatively easy. I just thought that it would be the most rewarding way to spend my life. And once I was introduced to the world of biochemistry I was hooked.”